Biograil

Biograil ApS was founded in 2019. It uses injection molding technology to manufacture a device housed in a standard-sized capsule, capable of delivering active substances into the walls of the gastrointestinal tract. The Biograil device avoids mechanical moving parts and leverages the body's own peristaltic forces to facilitate the effective delivery of biologics into the gastrointestinal wall.